Generics North America (NAFTA) Industry Guide 2017-2021
- Pages: 66
- Published: February 2018
- Report Code: MLIG1744-03
The NAFTA Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the NAFTA generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
– The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $1,11,669.7 million in 2016.The Mexico was the fastest growing country, with a CAGR of 14.3% over the 2012-16 period.
– Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $1,01,790.0 million in 2016. This was followed by Mexico and Canada, with a value of $5,430.1 and $4,449.6 million, respectively.
– The US is expected to lead the generics industry in the NAFTA bloc, with a value of $1,48,130.6 million in 2021, followed by Mexico and Canada with expected values of $10,769.6 and $6,409.3 million, respectively.
Scope
– Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA generics market
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA generics market
– Leading company profiles reveal details of key generics market players’ NAFTA operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA generics market with five year forecasts by both value and volume
– Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Reasons to buy
- What was the size of the NAFTA generics market by value in 2016?
- What will be the size of the NAFTA generics market in 2021?
- What factors are affecting the strength of competition in the NAFTA generics market?
- How has the market performed over the last five years?
- How large is the NAFTA generics market in relation to its regional counterparts?
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.